Failure of low-dose intravenous immunogl
โ
Keith S. Kanik; Cheryl H. Yarboro; Yaakov Naparstek; Paul H. Plotz; Ronald L. Wi
๐
Article
๐
1996
๐
John Wiley and Sons
๐
English
โ 262 KB
๐ 2 views
Treatment with high-dose (400 mg/kg/ day) intravenous immunoglobulin ( M g ) shows benefit in many autoimmune diseases but is very expensive. Low-dose M g has also been shown to be effective in inhibiting adjuvant arthritis in the rat. This pilot, randomized, double-blind, placebo-controlled trial w